Iranian researcher invents new drug for pancreatic cancer


TEHRAN (ISNA) - An Iranian researcher Ehsan Sarafraz-Yazdi from the University of New York has invented an anti-cancer peptide called PNC-27 for treating the most aggressive human cancer, pancreatic cancer.

Dr. Sarafraz-Yazdi is an assistant professor in the Division of Gynecologic Oncology at State University of New York (SUNY). He is also the Co-founder and director of NomoCan Pharmaceuticals which is a pre-‐clinical Limited Liability Company. NomoCan that offers biotechnology research services and develops products for diagnosis and treatment of cancer is based in Brooklyn, New York.

Sarafraz-Yazdi holds M.Sc. in Genetics from the University of Birmingham and Imperial College of London (U.K.) and Ph.D. in Cellular and Molecular Biology from SUNY.

His company offers the first in kind targeted therapy for the treatment of pancreatic cancer. Their technology not only makes available a highly selective and specific diagnostic and prognostic test for early detection, but more remarkably, it introduces a highly effective monoclonal antibody (mAb) drug for the treatment of pancreatic cancer in order to bring hope to patients and families affected by this devastating lethal disease.

“PNC-27 is now available for cancer patients in several countries” He said during an exclusive interview with ISNA on the sidelines of the 2nd international Nastaran Cancer Symposium in Mashhad, Iran.

 “There are about four or five different countries right now who are utilizing these peptides as therapies at their clinical trial.” He said.

“What I presented here this year was a brief summary of some of the clinical trials that we got from the patients and how they are effective in patients, I presented it as well as the generation of a new monoclonal anti-body that is specific for pancreatic cancer. The problem of pancreatic cancer is that currently it is the worst type of cancer, the survival rate for pancreatic cancer (the five year survival) is less than 5% which is sad.” He continued

According to Dr. Sarafraz-Yazdi, There are lots of NGOs in United States for cancer prevention and it is great to see that Mr Mir-Ahmadi started such an organization in Mashhad, Iran.

He emphasized that NCCP is aimed to bring the early on education diagnosis of prevention and it is very important because the best treatment for any diseases is prevention, it’s cheap and educating people about it is very easy.

End Item


You are replying to: .